The teams presenting at DiscoveryLab meetings are given guidance on development of their business plans by our panel of professional advisors.
Adam Elwi is a project manager with the Cancer Strategic Clinical Network supporting their clinical pathway initiatives. After completing a PhD in Oncology and 3 years of post-doctoral cancer research in area of chemotherapy drug resistance, he joined Alberta Health Services. Adam has over 6 years experience working in healthcare with a passion for tackling and solving complex problems in the cancer domain to transform how we deliver and measure care. He is currently completing his MBA through a joint degree with Queen’s University and Cornell University.
Aleina Spigelman, Manager, Access & Health Policy, Roche. Previously Market Access Manager, Purdue Pharma, Western Canada, worked with governments and other stakeholders to enable patient access to medicines, introduced new therapeutic areas; Territory Manager GSK; Epidemiologist, Communicable Disease Control, BC Centre for Disease Control; Epidemiologist, Centre for Health Evaluation and Outcomes Sciences, MSc in Health Care and Epidemiology, UBC.
Alice Reimer, Rockies Site Lead, Creative Destruction Lab; Vice Chair, Alberta Enterprise Corporation. She co-founded Calgary-based Evoco, leading the innovative SaaS firm from concept to acquisition. Alice was the CEO of Chaordix, a pioneering software leader in the crowdsourcing and open innovation space. BSc, MBA: U Calgary.
Amanda MacDonald, Partnerships and Commercialization Manager, Faculty of Science, U Alberta, connecting industry to partnership opportunities with researchers to help solve industry problems. Founded Insta-Cool Bands and developer of an instant cooling wearable. Previously with Edmonton Economic Development Corporation as a Community Manager, and at the College and Association of Registered Nurses of Alberta.
Amine Benmoussa, Principal in BDC Capital’s Healthcare Venture Fund. He serves on the Circle Cardiovascular Imaging and Clearwater Clinical board and the Philadelphia and Boston Canadian Technology Accelerators. He was previously part of the Life Sciences investment team at FSTQ and on the boards of Alethia Biotherapeutics, Clementia Pharmaceuticals, Interface Biologics and Milestone Pharmaceuticals. Amine holds a Bachelor of Computer Science from Concordia University, an MBA from HEC Montreal and trained in Private Equity and Venture Capital at Harvard Business School and in Corporate Governance at the Rotman School of Management.
Andrea Drager, Vice President at Azure Capital Partners, a San Francisco-based VC firm which invests in ~40 post-seed tech companies such as VMware, Bill Me Later, Calix, Cyan, Top Tier, TripIt and World Wide Packets. Based in their Calgary, Andrea evaluates and works with investment opportunities across Canada. She was previously a director with Monitor Deloitte, where she worked with consumer business and healthcare companies on innovation, marketing, and growth strategy. She cofounded a fashion and travel ecommerce company, and a received a Bachelor of Commerce degree from McGill.
Anita Ludwar, Venture Leader, Creative Destruction Lab. Previously Business Development Officer, Genome Alberta, a non-profit organization that initiates, funds and manages genomics research and partnerships in Alberta. Anita manages the Genomic Applications Partnership Program, a funding opportunity that supports downstream research and development projects addressing real world opportunities and challenges with genomics solutions. She holds a Master of Biomedical Technology degree, BSc (Hon) Chem and BSc CMMB from the University of Calgary.
Antonio Bruni , Business Development Manager, Edmonton Health City, which serves as a central connection point for Edmonton’s health innovation sector, working with partners who share a vision for excellence, have a culture of collaboration and are developing health innovations. PhD from U Alberta.
Arden Tse, Yaletown Partners Investment Manager of the Accelerate II Fund, an early stage B2B Tech investment fund focused on the Alberta startup community. His experience ranges from private sector portfolio management all the way to institutional investment management. Prior to joining Yaletown, he was the Manager of the UofA Venture Mentoring Service. Finance, leadership, and strategy are his main areas of focus when working with entrepreneurs. BSc and MBA in Finance from UAlberta. He is also a Certified Executive Coach through Royal Roads University.
Brad Thompson, CEO at Kickshaw Ventures and Wyvern Pharmaceuticals, and formerly CEO of Oncolytics Biotech and Synsorb Biotech. He has served as Chairman, Director and Audit Committee member on public company (NASDAQ, TSX, CDNX) boards of directors, and private company boards and industry groups including Chairman and Chairman Emeritus of BIOTECanada. BSc in Microbiology in the U Alberta and Ph.D. from U Western Ontario in Microbiology and Immunology.
Branka Barl, Industrial Technology Advisor at NRC-IRAP. Previously Principal Consultant, Barl and Associates, Scientific Leader, Natural Health Products and Functional Foods, Life Sciences Division, Alberta Research Council, Chief Scientist, New Era Nutrition Inc./Solo GI Nutrition, Adjunct Professor, Plant Sciences at U Saskatchewan. PhD in Food and Nutritional Sciences at U Manitoba, MSc in Biochemistry and Chem Eng Biotechnology degrees from U Belgrade.
Brett Clelland, Legal Counsel at AHS, focuses on the area of intellectual property law. Experience in the preparation and prosecution of patent, trademark and industrial design applications, providing patent and trademark opinions, trademark opposition proceedings, and copyright matters. Ph.D. from U Alberta in molecular biology, protein and nucleic acid biochemistry, and microbiology.
Brooks Tanner, Founder and President of Sunburst Ltd., is a Real Estate sales and marketing specialist who offers knowledge and expertise to developing sales and marketing solutions. Entrepreneurial spirit, work ethic and a strong technical background has contributed to this track record of successes. As a senior-level relationship builder, he mentors and manages teams who have increased operating results, delivered sales revenues and increased value.
Calvin Li, Industrial Technology Advisor - IRAP Program at National Research Council Canada. Previously Director Business Development, Glazr Software Company; Head of Information Technology, Wajax Equipment; Director, General Business Applications, Flint Energy Services; Director, Technology, statusfirm; VP, Technology, Castle Rock Research Corporation; Managing Partner, Vencom Business Solutions. MBA, International Business, U Alberta; B.Math, U Waterloo.
Carmen Wyton, Founder & President of Ripple Enterprise, has 25 years of experience in the non-profit sector – in health, human services, disabilities, education and employment. She has worked on policy development, advocacy and government relations in health, pharmaceuticals, non-profit, recreation and disability sectors.
Charles McOsker is Project Operations Director at Biomotiv and has over 30 years of experience in both the pharmaceutical and biotechnology industries. Before joining BioMotiv in 2012, he founded Airway Therapeutics, a biotech company developing therapeutics based on pulmonary research. He began his career at Procter & Gamble Pharmaceuticals, and held numerous management positions in drug discovery and development and was responsible for teams that discovered two products that successfully entered late-stage clinical development. He received his undergraduate degree in chemistry at Hope College in Michigan and his PhD in biochemistry and molecular biology at Cornell University.
Chen Fong is Co-Chair of the Global Strategy Board for the Creative Destruction Lab and funded over 50 companies in diverse technology sectors, with an emphasis in medical devices. He is a Professor Emeritus at the Faculty of Medicine, University of Calgary where he was formerly the Head of Radiology. He was the co-founder and board member of Calgary Scientific Inc. and is also on the board of Clarius Mobile Health, Cohesic Inc. and Innovere Medical.
Chris Carvalho, Health City Co-Lead, Working Groups, Edmonton Health City and Manager, Global Networks, Health Technology Assessment international (HTAi). Previously CEO, MicroHero Surveys and Senior Manager, Health Business Consulting, TELUS Health Transformation Services. Experienced management consultant with extensive experience in the healthcare technology space, led the design, development and implementation of healthcare information systems. BSc inHealth Information Science from U Victoria.
Chris Lerohl, Consultant, Campus Innovation Consulting Group and Co-Founder, CEO, Honest Dumplings. His interests include energy, innovation and entrepreneurship is fields including cleantech. Previously worked as Business Development Associate at TEC Edmonton and Business Development Manager Natural Sciences at UA Solve, and Advisor and Co-Founder, ABCampus Dates, and Big Brother at Big Brothers Big Sisters of Canada. MBA / MEng in Business, Engineering from UofA.
Chris Stewart, Healthcare and Life Sciences Marketing Professional, Principal at CLS Strategic Consulting, previously Team Lead at john st., Managing Director at Media Platforms, a full-service creative agency with a "Digital Engine", Group Account Director at Klick Health, a global digital communications agency specializing in end-to-end solutions for the healthcare industry, and VP, Client Services, GSW Worldwide. Awarded BComm in International Business and BSc in Physiology from the University of Alberta.
Colin Coros, Chief Commercialization Officer at Nanostics Inc. As Executive in Residence at TEC Edmonton, Colin provided mentorship in areas of health sciences, company mentoring, and strategic consulting. As the CEO of the Delta Genomics Centre, he built a national biobanking, genotyping and sequencing company for the livestock industry. He co-founded Helios Genomics, a metagenomics company specializing in the Energy sector. PhD in Biochemistry from U Western Ontario, an MBA from U Saskatchewan, and postdoc'd at the Wadsworth Centre in Albany and U Calgary.
Cory Janssen, Co-Founder, AltaML, Board Member, Edmonton Global, President of Galt Capital, and co-founder of Janalta Interactive, director at Brace Tool Inc. He was a co-founder of Investopedia.com, a financial education site, past-President of the Edmonton chapter for Entrepreneur’s Organization and member of the A100 and Venture Mentoring Service at U Alberta.
Craig Sherburne, TEC Edmonton, is a Corporate Commercial Lawyer and Patent Agent registered in the U.S. and Canada and has spent the past decade working in the venture space. With over 8 years of clinical development experience, as well as being well versed in Commercial and Residential construction, Venture Capital and Private Equity investment, he has assisted clients through corporate development lifecycles, from initial incorporation and corporate strategizing, through IP generation and management and through to eventual sale or M&A.
Daniel Salamon, Director, Strategic Partnerships, Alberta Cancer Foundation. Previously Senior Business Partner, Alberta Innovates - Technology Futures; Business Development, Electron Microscopy, National Research Council Canada. MBA in Technology Commercialization and B.Sc. in Computer Engineering, U Alberta.
Darrell Petras, Executive Vice President, Business Development at TEC Edmonton. Prior to this Darrell was a joint operator and owner of a diversified and award-winning farming operation. He also had a consulting practice working in agriculture, green energy, and IT. He belongs to the Alberta Institute of Agrologists, the Association of University Technology Managers (AUTM), and the Licensing Executives Society. Darrell holds a Bachelor of Science in Agriculture.
Darren Bolding, Regional Director, Alberta and British Columbia at Natural Products Canada, connects Alberta- and British Columbia-based companies, research institutions, investors, support organizations and others interested in opportunities in natural products, and provides guidance and advice on everything from intellectual property to regulatory and financial and competitive analysis. Previously at Alberta Innovates working with SMEs in a range of sectors gain access to capital and develop strategic commercial partnerships. MSc in Plant Genetics from the University of Saskatchewan, MBA in Technology Commercialisation and BSc in Genetics from the University of Alberta.
David Chavez, Vice President, Strategic Partnerships & Programs at Platform Calgary, leading the team that delivers programs to help entrepreneurs, researchers, and startups get from ideation to funding to commercialization. Previously led R&D and product management teams in Canada and China for Nortel and Ericsson. David holds a B.A.Sc. in Engineering Physics from the University of British Columbia. The Roy Group awarded David the Practice of Coaching badge which recognizes leaders interested in tools for positioning others to amplify performance, learning and engagement.
David Yiptong, Director, Programs at Platform Calgary. David provides early stage entrepreneurs with coaching and mentoring, and has over 10 years of combined experience in sales, product development and design. He has worked in industries ranging from air compressors, optical disc manufacturing, optical and wireless networking. While working for Nortel he helped support and engineer telecommunications networks for major carriers and corporations around the world. Previously, David spent time in an oil and gas EPCM working in project management and in the assessment and prioritization of in-situ projects for a major client. David holds a BSc in Engineering from McGill U and an MBA from U Calgary.
Deborah James is the Executive Director of Innovation in the Faculty of Medicine & Dentistry, University of Alberta and is CEO of eDJe Consulting Inc, a strategic healthcare consulting firm with a commitment to upholding the tenets of sustainable health and health care. Deborah’s ability to conceptualize and persuasively deliver new ideas contributes to her success at business development. She has expertise in precision medicine, in vitro diagnostics, pharmaceutical development, genomics, immunology and translational sciences.
Derek V Exner, Professor, Libin Cardiovascular Institute of Alberta, Canada Research Chair in Cardiovascular Clinical Trials and Associate Dean, Clinical Trials, Cumming School of Medicine. Chairman, Advisory Board, Analytics for Life. Advisor, Murmur. Master's in Public Health: Johns Hopkins Bloomberg School of Public Health; MD: U of Saskatchewan.
Elisa Park Kim, Manager of Health Innovation, University of Calgary, Hunter Hub for Entrepreneurial Thinking & Cumming School of Medicine, University of Calgary. Previously Project Manager and Communications Coordinator, McCaig Institute for Bone and Joint Health, University of Calgary. Master’s Degree, International Relations and Affairs, Yonsei University and BA in Sociology & Spanish, University of Toronto.
Eric Brown, Associate Investment Advisor at Canaccord Genuity Wealth Management, working with business owners to reach their goals and make responsible financial decisions. He was previously an Investment Associate at Scotia McLeod. Eric holds a BA from the University of Alberta and a Chartered Investment Manager designation from the Canadian Securities Institute; he is licensed to serve clients in Alberta, British Columbia, Ontario and Saskatchewan.
Gabe Kalmar, Entrepreneur in Residence at UBC and Innovation Boulevard, and Mentor in Residence for Venture Connection at Simon Fraser University. He provides strategic consulting to early stage pharmaceutical companies on operations, technology development, and merger and acquisition planning. He has had senior roles at Genome BC, and was the President and CEO of the Pacific Autism Family Network. He is also on the board of companies including MRMProteomics and HeadCheck Health. Dr. Kalmar holds a BSc in Biochemistry and MSc in Virology from UBC, and a PhD in Virology from SFU.
Graham Anderson, Program Manager, Alberta Innovates, Health, began his career working as a community pharmacist, where he gained insight into the healthcare system from a pharmacy perspective. He became co-owner of Sherwood Dispensaries in 2012 and operated the pharmacy for two years, launching initiatives including a travel and immunization clinic, blood pressure clinic at a local retirement home and a mental health outreach program in collaboration with two psychiatrists in the community. Graham is completing an MBA degree at the UofA, with a specialization in Innovation and Entrepreneurship.
Gordon Hamilton, Director of MathPickle.com, a web site to inspire K-12 communities worldwide supported by Patreon, Nancy Blachman and the American Institute of Mathematics. He is a Mathematician in Residence at Rosedale School, a Game Designer Game Artisans of Canada with successful games on the market, and a member of Innovate Calgary. He was awarded a MMath degree from the University of Waterloo and a PhD in Mathematical Biology from the University of Calgary.
Houston Peschl, Instructor of entrepreneurship, innovation and sustainable development at the Haskayne School of Business. Formerly Director of Operations and Sustainability of DIRTT Environmental Solutions, co-founder of Creating Eudaimonia; a firm dedicated to building capacity to start ups and small companies across Canada. He led multiple Alberta companies to become B Corp Certified, the most rigorous social enterprise certification globally. Co-founde of The Collective and previously director of Sustainability Resources Ltd.
Ian Murray, President & General Counsel of IMC, has extensive experience providing services to private and public clients, with a focus on the natural resources and manufacturing industries. Prior to founding IMC in 1989, Ian articled for the law firm Parlee McLaws, worked in the acquisitions department of Varity Corporation and was Executive Assistant to the Alberta Minister of Forestry, Lands and Wildlife. He has experience in the areas of project management, commercial negotiations, finance, law and government. His work has included providing clients with active hands-on project management of large greenfield projects as well as transition management services for large private and public sector clients during restructurings or periods of change.
Isha Katyal, Manager, Centre for Innovation and Applied Research at Concordia University of Edmonton. Previously, Technology Management Officer, TEC Edmonton and Business Analyst, Evalueserve. PhD in Microbiology from U Saskatchewan, MSc in Biotechnology from Thapar Institute of Engineering and Technology and BSc in Zoology/Animal Biology from Delhi University.
Jacki Jenuth, Partner at Lumira Capital, helping to build transformational health and life science companies. Previously Manager Custom Software Solutions/Research Scientist at Base4 Bioinformatics / Opentext Corp. Postdoc'd at McGill U. Venture Capital Executive program at UC Berkeley. PhD in Purine Biochemistry, Molecular Biology, UCalgary.
Jairo Riveros, Director at Monitor Deloitte. Financial services strategy executive and entrepreneur with experience across North America. Strong track record of partnering to set strategic imperatives and build-out transformation initiatives. Former Managing Director at Artemis Worldwide, focussing on identifying new business opportunities and lead sale/engagement process, and spearheading development of a startup investment platform facilitating the research for companies seeking investors, and investors seeking opportunities in emerging markets. Previously Head of Corporate Strategy at AIMCo, one of Canada’s largest and most diversified institutional investment fund managers.
Jake Burlet, Board Director of United Farmers of Alberta, A&H Steel Ltd and Wholesale Sports Outdoor Outfitters and Waskesiu Foundation Inc, Partner at Grey Owl Investments Ltd, President, Venture West Veterinary Services Ltd. Previously Managing Partner of Landco Management, President & CEO, Viewtrak Technologies Inc, Co-CEO of Cattle & Co. Investments Inc., Managing Partner of Camrose Veterinary Group. ICD.D in Corporate Governance at U Toronto Rotman School of Management and MBA from U Western Ontario.
Jane Halford, Co Founder, BOLT Transition and President, Halford Consulting Inc and previously CEO and Executive Director of the Institute of Chartered Accountants of Alberta. Jane has also served the technology commercialization industry as an executive-in-residence at TEC Edmonton, and is currently on the boards of Farm Credit Canada, United Way of the Alberta Capital Region, Institute of Corporate Directors Edmonton Chapter, Hyduke Energy Services, Delta Genomics, and the Canadian Angus Foundation. Bachelor of Commerce, Accounting from the University of Alberta.
Janelle Goulard, Director of Health Investment, Pangaea Ventures Ltd. has experience in healthcare, both in strategic and operations consulting and private investments. She spent most of her career at GE Healthcare, based in both North America and Europe. She worked with both private and public health organizations and launched a startup that became a joint venture between GE and Microsoft. She is a master change agent and Lean Black Belt certified. She brings her experience as an Associate with a leading Canadian private equity firm. Janelle has an MBA from the University of British Columbia in Entrepreneurship and Innovation and a BComm from McGill University.
Jason Ding, Edmonton Corporate Finance Leader and National Biotechnology Leader for Deloitte Canada. Jason is a Chartered Accountant and Chartered Business Valuator with particular expertise in the technology (life sciences, information technology and clean technology) industry and has worked with national and international public company clients in sectors such as biotechnology & life sciences, software, general technology, regulated utilities and oil & gas services. He has experience working in the area of licensing, partnering & alliances, M&A, equity and debt financing, business valuations, corporate finance, and general financial advisory service lines for technology companies.
Jen Bisson, CEO, Mountain Integrated Medical Devices, Co-Founder, Pretium Inc. Previously Lead Auditor, Med Tech Consulting, Charge D'Affairs - Project Manager, LNE/G-MED North America, Project Engineer, Baylis Medical Company, Engineering, University of Calgary.
Jennifer Hamilton, Senior Director, New Ventures (Canada) and Advisor, Impact Investing, Johnson & Johnson Innovation. She also serves as the industry representative on the CIHR Standing Committee on Ethics. Previously a Venture Partner at Nomura Phase4 Ventures and Investment Director with Rothschild Asset Management. MSc and a PhD in Experimental Pathology/Lipid Metabolism from UBC and a BSc from the University of Guelph.
Joanna Preston is Associate Director of the Technology Management team (Health Sciences) at TEC Edmonton, and oversees the provision of IP management and commercialization services to inventors in health sciences. She spent a decade in production roles in the biomanufacturing industry, first with a private Alberta firm, and later with the Alberta Research Council. She holds a BSc in Genetics and an MBA in Technology Commercialization from the University of Alberta. She is a member of the Association of University Technology Managers and the Licensing Executive Society. She is also a case study discussion leader for the Canadian Intellectual Property Office and a grant reviewer for the CIHR.
Joseph Tucker is the CEO and co-founder of Epimeron, and has served as CEO, CFO and Vice President for several biotech companies, both publicly listed and privately held. He has taken companies from incorporation through to acquisition, out-licensing, and stock market listing. Joseph has raised millions in company funding through capital market equity financings and from non-dilutive funding sources. He holds more than 20 issued or pending patents, has a Ph.D. in Biochemistry and Molecular Biology from the University of Calgary, and is a member of the Board of Directors of BioAlberta.
Julie Woda is Director of Technical Operations at BioMotiv, and has over 23 years of biological research and drug development experience. Prior to BioMotiv, she worked as Director of Translational Research for Juventas Therapeutics, overseeing preclinical development of novel biologics and at Athersys developing cell therapy for the treatment of cardiovascular, immunological, and neurological indications. Juliana completed her PhD in Biological and Biomedical Sciences at Harvard U, specializing in Cell and Developmental Biology. Her postdoctoral fellowship with Massachusetts General Hospital focused on examining the normal function of the protein mutated in Huntington’s Disease.
Justin Riemer, Senior Provincial Director, Innovation Partnerships at Alberta Health Services. Leads the development of strategies and partnerships to accelerate the adoption and diffusion of new health technologies and processes that will improve patient outcomes and add value to Alberta's health care system. Previously as Assistant Deputy Minister (ADM) of Alberta Health’s Innovation and External Relations Division, Justin lead a team to facilitate increased innovation adoption in the health care system with the goal of building the strongest health innovation ecosystem in Canada.
Kathryn Ambler, Team Lead, Innovation Evidence & Impact at Alberta Health Services. Previously Manager of Health Technologies and Services Policy at the Government of Alberta, Research Coordinator of the Pediatric Centre for Weight and Health at the University of Alberta, and Manager of the Treatment and Research of Obesity in Pediatrics In Canada, Canadian Obesity Network – Réseau Canadien en Obésité.
Kevin Ens, Executive-in-Residence at TEC Edmonton. Kevin is a senior executive with over 30 years of strategic and operational management experience in biotechnology/biopharma and medical devices. A broad track record of success spanning sales and marketing to operations and general management with a strong business development focus. Entrepreneurial and thrives on the challenges of technology commercialization and building value in start-up and early-stage companies.
Kristy Lonergan, Director, Corporate Planning, Centre for Drug Research and Development (CDRD), with experience evaluating, commercializing and marketing life science technologies and products. Previously Business Development Analyst, CDRD Ventures, Inc., Product Marketing Manager, STEMCELL Technologies. Diploma in Business Administration: Simon Fraser U, MSc Neuroscience: McGill U, BSc: U Victoria.
Lin Tang, Innovation Manager, Medical and Life Sciences at Innovate Calgary, with experiences in research partnership, industry liaison and intellectual property management. She works closely with researchers and research institutes at U Calgary and Pharma/Biotech companies in developing, facilitating and managing research partnerships. She helps researchers to commercialize research and services by aligning research expertise with industry needs and providing project management and IP management expertise. She obtained her PhD in molecular biology from the Faculty of Medicine and received her postdoctoral training in stem cell biology from the Faculty of Veterinary Medicine at U Calgary.
Marlise Stewart, Business Development Manager - Life Sciences, Calgary Economic Development. Previously Business Development Manager, Meetings & Conventions Calgary, Corporate Sales Manager, Hotel Arts Group, Director Sales & Marketing, True Key Hotels and Resorts. BA Psychology & Business Development, U Manitoba.
Marita Hobman, Assistant Chair, Administration, Department of Biochemistry, previously served as the Director, Intellectual Property and Business Development at Biomira/Oncothyreon for over ten years. She contributed to University of Alberta research management and commercialization as the Executive Director, Financial Operations and Strategic Development for Livestock Gentec and as Senior Manager, Partnerships, at the Research Services Office. Her experience spans IP management, technology licensing, industry/academia collaborations and contract negotiations. Marita has a Ph.D in virology from University of Goteborg, Sweden, and an MBA from University of Alberta.
Marc Leduc, Senior Provincial Director, Innovation & Research Management at Alberta Health Services. Previously Executive Associate to the Executive Vice President, Strategy and Performance. Marc was awarded a Master of Arts in Political Science and Government from the University of Alberta.
Mark Benning is an experienced entrepreneur who founded and led four investor-backed, technology startups in Silicon Valley, California over a 20-year period. As an Executive in Residence at TEC Edmonton since 2017, he acts as a mentor to entrepreneurs and executives and as an advisor to TEC’s Business Development team. Over the years, he has worked for various private equity and venture capital firms and has raised over $100 million in angel and venture funding for his startups and others he advised. He has a BA in Economics from Harvard University and an MBA from Stanford University, where he focused on leadership and entrepreneurship.
Matthew Parker, Manager of Health ML at AltaML, is focused on leveraging AI to improve healthcare. In his role, Matt is leading the team at AltaML to codesign solutions in the areas of healthcare and life sciences. Previously, Matt was working in commercialization and innovation in Toronto for Sinai Health System. Matt has a PhD in Biochemistry from the University of Victoria and an MBA from the Schulich School of Business with a specialization in Health Industry Management.
Michael Bosdet, President, TSGI Corporation, a professional services firm with over 20 years of experience assisting companies with their Scientific Research and Experimental Development (SR&ED) claims. He is a PhD scientist skilled in public speaking, data analysis, and business development, and was formerly an award-winning post-secondary instructor and researcher. In his time at TSGI, he has had success helping all sizes of technology companies in numerous industries benefit from SR&ED. is an experienced professional with a demonstrated history of growth and leadership.
Michele D'Elia, Director Medical Affairs, Roche Diagnostics, providing advice on clinical and technical validation for novel diagnostic assays including sensitivity, specificity, delivery route and market demand. PhD in Immunology and Virology and MSc in Experimental Health Sciences, INRS Institut Armand-Frappier BSc in Microbiology and Immunology, Université de Montréal.
Michelle Normand, Investment Attraction Manager, Agriculture and Forestry, Government of Alberta provides coaching on how to improve productivity, profitability and sustainability, and provides assistance in market development, consumer education, leadership development and lean thinking. Her focus includes the food and value added industries. Her previous positions include Senior Manager, Alberta Livestock and Meat Agency, Industry Development Officer, Alberta Agriculture and Rural Development, and U.S Trade Director, Alberta Economic Development. Certificate in Community Economic Development from Simon Fraser University and Bachelor of Arts from the University of Alberta.
Mike Riou, Technology Development Advisor, Alberta Innovates, coaches SMEs and provides connections to the innovation ecosystem. Previously as President, Three R Consulting, he provided advisory and management consulting services in technology commercialization and business strategy. Co-Founder of Vario Ventures, supporting entrepreneurs and investors in identifying next-steps including IP sales and capital return. Corporate Director, Newcastle Medical Investments, investing in early stage medical device companies. Previously Business Development Manager of Technology Commercialization Partner, and Product Development Engineer at D-Tex, which developed a platform for bacteria detection system for medical and food safety applications. MBA and Executive Education from University of Alberta.
Niall Kerrigan, Program Officer at Genome Alberta, using his skills to help drive the application of genomic technologies in Alberta’s industries. He is a strong proponent that the implementation of genomic technologies can substantially decrease the environmental impact of industry and help lead society into a more sustainable future. He received a BSc in Zoology and Master of Biomedical Technology from U Calgary.
Nima Najand is a technology transfer professional at Innovate Calgary with experience in IP and licensing. He obtained his undergraduate degree and MSc from the University of Alberta in Molecular Genetics and Cell Biology and his PhD from the faculty of Medicine at the University of Calgary. As Associate Director, Business Development for the Life Sciences Innovation Hub (LSI Hub), Nima is currently working to build the life science ecosystem in Calgary through the space and programming offered at the LSI Hub. He draws upon his extensive experience in health science and research commercialization to drive research from bench side to bedside.
Patty Wickson, with a passion and purpose to develop people to be their best whether in the boardroom or front lines. Empowering, mentoring, leading and giving back to others are the goal. Leading health innovation, impact, evaluation transforming AHS into an innovative health hub to improve outcomes for Albertans. Extensive leadership experience for over 17 years with clinical, operational, management, strategy, quality improvement, project management, stakeholders engagement, person centered care and research/innovation.
Peter Ciechanowski, Lawyer, Alberta Justice and Solicitor General - Energy Legal and Research Analyst, with a Juris Doctor (J.D.) in Law and Master’s degree in Public Health with Specialization in Environmental and Occupational Health from the University of Alberta.
Ranice Macyk, Senior Manager, Entrepreneur Capital at ATB Financial, leading the development of unique financial products for Alberta entrepreneurs, including ATB’s first Solar Financing Program. CSBFA Specialist, promoting and Educating Borrowers on the Canadian Small Business Financing Program. Previously employed as a Senior Credit Analyst, Executive Assistant to Vice President, Agriculture and the Independent Business and Agriculture team. Bachelor of Arts in Psychology, Sociology from the University of Alberta.
Ray Bergstra is the President and CEO of MTN Consulting Associates, an Edmonton-based market research, technology commercialization, and project management consulting firm specializing in science and technology initiatives and businesses in Alberta. Ray has nearly 30 years of industry experience in a range of sectors, including agriculture, oil & gas, industrial biotechnology, forestry, renewable energy, food processing, specialty chemicals, and polymers. Through MTN Consulting Associates, Ray has contributed industry and business development strategies to more than 75 public and private technology development and commercialization initiatives.
Ray Muzyka is the CEO & Founder of Threshold Impact. He trained as a medical doctor and co-founded and led BioWare, a video game development studio. At Threshold Impact he focused on sustainable, profitable impact investing: mentoring and angel investing in information technology, new media, and medical innovations with social entrepreneurs. He is a member of the Young Presidents’ Organization, the A100, the Ashoka Support Network, chairs of the UofA's entrepreneur Venture Mentoring Service and is a venture advisor at iNovia Venture Capital.
Ryan Heit has a diverse background in research, technology commercialization, business development, and financing early stage companies. Ryan has provided business planning and company development for many early-stage, technology-based ventures in health-related fields in his position at TEC Edmonton and as an independent consultant. Additionally, he has helped multiple Alberta companies in obtaining financing in his role with the angel investing network, TEC VA. He received his Masters in Experimental Oncology and his Masters of Business Administration with a specialization in Technology Commercialization from the University of Alberta.
Samarendra Maiti, Distinguished Scientist at Brass Dome Ventures, obtained his PhD from the Kalyani University, West Bengal, India in 1980. He has over 35 years of experience in medicinal & synthetic chemistry and has collaborated with large pharmaceutical companies in important therapeutic areas such as, antimicrobials, cardiovascular, CNS, and metabolic disorders. He has written chapters in two books, written five reviews, and has 15 patents and 60 publications. During his research career Dr. Maiti was involved in three antimicrobial projects that successfully produced three clinical candidates, one of which is already in the market, and two that are in development.
Sameeh Salama, Vice-President of Business Development at Brass Dome Ventures, and VP of Fedora Pharmaceuticals. He was formerly VP of NAEJA Pharmaceuticals Inc. where he was involved in licensing and partnership agreements, including of Beta-lactamase inhibitors to Fedora Pharmaceuticals and later to F. Hoffman La Roche in a US$750 million deal. Dr. Salama was previously a Director of Microbiology at SynPhar laboratories Inc. He received his PhD in Medical Microbiology from the University of Salford, U.K. and postdoc’d at the UoFA.
Sandra Spencer, Manager of the UAlberta Health Accelerator. Sandra also founded Nimble Strategizing two years ago where she works directly with entrepreneurs to validate and build business models, identify and pursue financing, and create overall strategies to scale - including working with Volition, a startup advisory and events firm. In that time she also ran Valhalla Private Capital's BaseCamp program on raising capital, supported the growth of 321 Growth Academy Accelerator programs supporting Sales, Marketing, and HR, and executed the National Angel Capital Association's (NACO) World Angel Investment Summit in 2018 and 2019. Previously at NAIT in the Office of Research & Innovation running startup & accelerator programming and ran Alberta Women Entrepreneur's PeerSpark program.
Sandra Stabel, a Program Manager for Alberta Innovates, has spent most of her career working in Primary Care. She completed a BSc in Kinesiology and spent 10 years working as an Exercise Specialist helping patients living with chronic health conditions. She focuses on Quality Improvement, helping family medical practices improve clinical processes, access and patient centered care. Most recently, she completed a MBA at the UofA. She currently works with Alberta Innovates to coordinate and catalyze research and innovation efforts within the health system, government, industry and community organizations.
Scott Reed is the Director, Business Development at Brass Dome Ventures. He obtained his Chartered Financial Analyst designation in 2007 and his MBA in 2013. He has been working in the financial and consulting industry since 2002. He has worked in both small and large organizations and has a variety of experience.
Sean DeWitt, Program Manager at Alberta Innovates, is responsible for grant and investment portfolios including Precision Health, Primary Care, and Health System Research and Innovation. He has worked in operations and manufacturing with Afexa Life Sciences, in sales with Novartis and Bristol-Myers Squibb, and as a Primary Care Manager with Alberta Health Services. BSc in Biological Sciences and an MBA from U Alberta.
Shaheel Hooda, Executive in Residence for and Program Director for TEC’s T-Squared Accelerator. Served as a board member at Login Radius, a high growth Software as a Service (SaaS) company that recently raised $17 million from top Tier investors including Microsoft Ventures (M12) and Trident Ventures. Was CEO of two startup software companies, Director of Business Development for a US enterprise software company, and previously a strategy consultant at McKinsey & Company, where he launched one of Canada’s first online banks. He has been involved in starting or running more than 15 startup businesses, actively advised hundreds of entrepreneurs.
Stace Wills, Director, New Ventures at Innovate Calgary, oversees a portfolio of 90 UCalgary spin-out companies. Previously co-founded innovation programs including the KICS Labs at SAIT, Green Tech Mentors program, and Kinetica energy tech accelerator and CEO of Direct-C Ltd. He served in senior corporate development roles with Elluminate Inc. and Alta Genetics Inc. He co-founded Accolade Capital Inc. and The Strongest Oak Foundation, and served on boards including Helix Biopharma and SeeO2 Energy Inc. Stace has a Chartered Investment Manager designation, as well as a B.Comm. degree from the University of Calgary.
Stephen Urquhart, Managing Director, ACG Inc. Works directly with multinational organizations, start-ups and SME’s in a variety of countries, facilitating acceleration from concepts to commercial success utilising strong market access and government relations skills. MBA from U Athabasca and BSc in genetics from U Alberta, certifications in Health Care Economics, Engineering, LEAN execution, and Project Management.
Svenja Chenikel, Senior Trade + Investment Officer, Government of Alberta. Previously a Commercial Officer at Canadian Consulate Munich - Ontario International Marketing Centre. Dipl. Betriebswirt from the University of Applied Sciences, Worms and DEUG Lettres Modernes/Anglais from the Université Paul Valéry (Montpellier III).
Ted Yoo, Partner at Bennett Jones, is a registered patent and trademark agent in both Canada and the United States. His practice covers all matters related to intellectual property, but is particularly focused on the preparation and prosecution of patent applications, licensing, patentability and freedom to operate opinions. With a background in microbiology and chemistry, and an enduring personal interest in all areas of technology, Ted acts for clients in the fields of biotechnology, nanotechnology, pharmaceuticals, forestry and agriculture, and the oil and gas industry. He is a Sessional Lecturer in IP Law at the Faculty of Law, University of Alberta and has lectured in the Faculty of Engineering, University of Alberta.
Thach Lang, Alberta Health Services, provides business, corporate and consulting services. Focus on technology evaluation (HTA, technology appraisal, pre-market assessment, reviews), IP management related to health care innovations and funding for interventions/use in health system. Former researcher and lawyer by training, instructor and program development for health and medical sciences courses, skilled in research methods, patent drafting/prosecution and IP law and practice. Leads multidisciplinary teams and health care projects, developing processes and policies.
Thomas (Yong-il) Ahn, CEO at Mad Ventures, which is pioneering a novel model of startup investment which leverages Internet technologies and allows early-stage innovators and start-ups to incubate without the need to physically relocate, thus minimizing downtime and business interruption. The process is more than just providing money and management expertise - it offers extensive business connections around the world, helps Canadian businesses secure business opportunities in the Asia Pacific region, and ensures the right mix of R&D, Venture Capital, and business development for promising innovators to realize their visions.
Tom Ogaranko, Co-Founder and Principal at Tessellate Inc, which works with companies and public innovation organizations to implement a systematic approach to innovation management and strategic sourcing. He is a serial entrepreneur and seasoned technology executive with experience in several IT, Medtech and business service startups, and government agencies.
Tony Wigglesworth is the Associate Director of Science and Engineering at Innovate Calgary, advancing new technologies from the research lab through to industrial demonstration and towards commercial success, fostering partnerships with Universities, government labs and strategic industry partners. His portfolio of projects span nanotechnology, printed and microelectronics, advanced coatings, medical devices and clean tech from the concept phase through to product launch and new venture creation. He received his PhD in Chemistry from Simon Fraser U and postdoc'd at the Swiss Federal Institute of Technology.Ubaka Ogbogu, Associate Professor, Faculties of Law and Pharmacy & Pharmaceutical Sciences at the UofA, with interests in health law, science and health policy, bioethics and biomedicine, legal history of public health and health care in Canada and the law of torts including medical malpractice and governance of novel and controversial health care technologies. He holds a research appointment as the Katz Research Fellow in Health Law and Science Policy and is a member of the Faculty’s Health Law Institute.
Vinoth Babu, Manager, Client and Marketing Support at Ian Murray & Company, is a MBA graduate (Natural Resource, Energy and Environment Specialization) from the University of Alberta with experience working in technology commercialization, financial analysis, and business management areas. His experiences include feasibility study development, business plan development, opportunity assessment, business valuation, financial modelling, market research and competitive benchmarking.
Investment and business advisors are welcome to enquire about joining.
People presenting at DiscoveryLab meetings are asked to share their plans in a round table discussion, and are free to share contact details, meet with advisors and perform due diligence before signing contracts or taking investments. Technology transfer experts and firms including TEC Edmonton are available to assist.